MYC was recently reported to promote immune-suppression in triple-negative breast cancer via inhibition of STING-IFN-I signaling in a tumor cell-intrinsic fashion via direct transcriptional repression50. This evidence concerns the gene STING1 and triple-negative breast carcinoma.